Jamie Michael, MD, highlights a study exploring the impact of MRI and genomics on "extreme" grade reclassification in men on active surveillance.
Jamie Michael, MD
Advertisement
Articles by Jamie Michael, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Pivotal phase 3 trial launches of rinzimetostat plus darolutamide in mCRPC
2
Ravi Munver, MD, highlights study of first- and second-generation Aquablation systems
3
First Assist: Early Cystectomy in Non–Muscle Invasive Bladder Cancer, with Matvey Tsivian, MD
4
Genomic Prostate Score may help refine risk assessment in localized prostate cancer
5